KIORA PHARMACEUTICALS INC (KPRX)
US49721T3095 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.45M | 5.96M | 7.85M | 1.19M | 3.78M | |||
| Receivables | 2.05M | 1.37M | 530.00K | 90.00K | 0.00 | |||
| Other Current Assets | 233.38K | 340.00K | 610.00K | 450.00K | 540.00K | |||
| Total Current Assets | 4.74M | 7.68M | 8.99M | 1.73M | 4.32M | |||
| Non-Current Assets | ||||||||
| PPE Net | 114.96K | 170.00K | 280.00K | 110.00K | 20.00K | |||
| Goodwill | N/A | N/A | 0.00 | 3.48M | 1.53M | |||
| Intangibles | 8.81M | 10.74M | 10.77M | 9.73M | 4.13M | |||
| Other Non-Current Assets | 45.03K | 80.00K | 90.00K | 100.00K | 110.00K | |||
| Total Non-Current Assets | 8.97M | 11.00M | 11.14M | 13.43M | 5.79M | |||
| TOTAL ASSETS | 13.71M | 18.68M | 20.13M | 15.16M | 10.11M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.36M | 1.76M | 1.42M | 1.34M | 1.20M | |||
| Accounts Payable | 206.26K | 1.01M | 160.00K | 430.00K | 210.00K | |||
| Other Current Liabilities | 64.56K | 510.00K | 30.00K | N/A | N/A | |||
| Total Current Liabilities | 1.63M | 3.27M | 1.61M | 1.77M | 1.41M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 280.00K | 0.00 | |||
| Deferred Taxes/Income | 779.44K | 690.00K | 800.00K | 730.00K | 370.00K | |||
| Other Non-Current Liabilities | 5.19M | 3.31M | 3.14M | 5.38M | 1.71M | |||
| Total Non-Current Liabilities | 5.97M | 4.00M | 3.94M | 6.39M | 2.08M | |||
| TOTAL LIABILITIES | 7.60M | 7.27M | 5.55M | 8.16M | 3.49M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -146.98M | -134.46M | -120.88M | -108.34M | -100.25M | |||
| Additional Paid In Capital | 153.19M | 146.04M | 135.42M | 115.28M | 106.69M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 77.08K | 20.00K | 130.00K | 60.00K | 40.00K | |||
| Other Shareholders' Equity | -182.80K | -180.00K | -90.00K | 0.00 | 140.00K | |||
| Shares Outstanding | 7.71M | 1.80M | 320.00K | 140.00K | 100.00K | |||
| Tangible Book Value per Share | -0.35 | 0.37 | 11.91 | -44.36 | 9.60 | |||
| Total Shareholders' Equity | 6.11M | 11.41M | 14.58M | 7.00M | 6.62M | |||
| TOTAL LIABILITIES AND EQUITY | 13.71M | 18.68M | 20.13M | 15.16M | 10.11M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.04 | N/A | |||
| Current Ratio | 2.90 | 2.35 | 5.58 | 0.98 | 3.06 | |||
| Return On Assets (ROA) | -95.14% | -72.70% | -68.41% | -53.36% | -70.23% | |||
| Return On Equity (ROE) | -213.51% | -119.02% | -94.44% | -115.57% | -107.25% | |||
All data in USD